News Gerardo Dueñas 7/28/25 Gerardo Dueñas 7/28/25 New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer's Disease Presented at the 2025 Alzheimer's Association International Conference Jul 28, 2025 Read More Gerardo Dueñas 4/22/25 Gerardo Dueñas 4/22/25 Veravas Launches VeraBIND™ Tau - First Blood Test to Detect Alzheimer's-Related Tau Pathology Apr 22, 2025 Read More Gerardo Dueñas 12/5/24 Gerardo Dueñas 12/5/24 Veravas Improves Diagnostic Tests by Purifying Samples Dec 05, 2024 Read More Gerardo Dueñas 11/20/24 Gerardo Dueñas 11/20/24 Veravas Completes Analytical Verification Study of the VeraBIND Tau Assay, a Groundbreaking Test to Measure Alzheimer's Tau Pathology in Blood Nov 20, 2024 Read More Gerardo Dueñas 11/7/24 Gerardo Dueñas 11/7/24 VeraBIND Tau is being developed jointly with Veravas, Inc. and Phanes Biotech, Inc. Nov 07, 2024 Read More
Gerardo Dueñas 7/28/25 Gerardo Dueñas 7/28/25 New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer's Disease Presented at the 2025 Alzheimer's Association International Conference Jul 28, 2025 Read More
Gerardo Dueñas 4/22/25 Gerardo Dueñas 4/22/25 Veravas Launches VeraBIND™ Tau - First Blood Test to Detect Alzheimer's-Related Tau Pathology Apr 22, 2025 Read More
Gerardo Dueñas 12/5/24 Gerardo Dueñas 12/5/24 Veravas Improves Diagnostic Tests by Purifying Samples Dec 05, 2024 Read More
Gerardo Dueñas 11/20/24 Gerardo Dueñas 11/20/24 Veravas Completes Analytical Verification Study of the VeraBIND Tau Assay, a Groundbreaking Test to Measure Alzheimer's Tau Pathology in Blood Nov 20, 2024 Read More
Gerardo Dueñas 11/7/24 Gerardo Dueñas 11/7/24 VeraBIND Tau is being developed jointly with Veravas, Inc. and Phanes Biotech, Inc. Nov 07, 2024 Read More
